Eric J. Niesor

A New Selective Peroxisome Proliferator-Activated Receptor γ Antagonist with Antiobesity and Antidiabetic Activity

Jennifer Rieusset, Fethi Touri, Liliane Michalik et al. · Molecular Endocrinology · 2002 · 211 citations · Full text

Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib

Jean‐Claude Tardif, Éric Rhéaume, Louis‐Philippe Lemieux Perreault et al. · Circulation Cardiovascular Genetics · 2015 · 183 citations

A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor-γ (PPARγ) Recruits PPARγ-Coactivator-1α, Prevents Triglyceride Accumulation, and Potentiates Insulin Signaling in Vitro

Elke Burgermeister, Astride Schnoebelen, Angele Flament et al. · Molecular Endocrinology · 2005 · 154 citations

Novel Partial Agonist, Insulin Signaling, Molecular Pharmacology +20

Modulating cholesteryl ester transfer protein activity maintains efficient pre-β-HDL formation and increases reverse cholesterol transport

Eric J. Niesor, Christine Magg, Naoto Ogawa et al. · Journal of Lipid Research · 2010 · 152 citations · Full text

Lipid Peroxidation, Dalcetrapib ≤3 µM, Cellular Pharmacology +16

The Bile Acid Nuclear Receptor FXR and the Bile Acid Binding Protein IBABP Are Differently Expressed in Colon Cancer

Andrea De Gottardi, Fethi Touri, Christoph A. Maurer et al. · Digestive Diseases and Sciences · 2004 · 135 citations

Biliary Tract, Biliary Cancer, Liver Physiology +7